143 related articles for article (PubMed ID: 25651604)
1. Medication adherence and readmission after myocardial infarction in the Medicare population.
Zhang Y; Kaplan CM; Baik SH; Chang CC; Lave JR
Am J Manag Care; 2014; 20(11):e498-505. PubMed ID: 25651604
[TBL] [Abstract][Full Text] [Related]
2. Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors.
Zhang Y; Baik SH; Chang CC; Kaplan CM; Lave JR
Am Heart J; 2012 Sep; 164(3):425-433.e4. PubMed ID: 22980311
[TBL] [Abstract][Full Text] [Related]
3. Association of US Centers for Medicare and Medicaid Services Hospital 30-Day Risk-Standardized Readmission Metric With Care Quality and Outcomes After Acute Myocardial Infarction: Findings From the National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines.
Pandey A; Golwala H; Hall HM; Wang TY; Lu D; Xian Y; Chiswell K; Joynt KE; Goyal A; Das SR; Kumbhani D; Julien H; Fonarow GC; de Lemos JA
JAMA Cardiol; 2017 Jul; 2(7):723-731. PubMed ID: 28445559
[TBL] [Abstract][Full Text] [Related]
4. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.
Tuppin P; Neumann A; Danchin N; de Peretti C; Weill A; Ricordeau P; Allemand H
Arch Cardiovasc Dis; 2010; 103(6-7):363-75. PubMed ID: 20800800
[TBL] [Abstract][Full Text] [Related]
6. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.
Lauffenburger JC; Robinson JG; Oramasionwu C; Fang G
Circulation; 2014 Feb; 129(7):754-63. PubMed ID: 24326988
[TBL] [Abstract][Full Text] [Related]
7. Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid-Eligible Adults With Myocardial Infarction.
Doll JA; Hellkamp AS; Goyal A; Sutton NR; Peterson ED; Wang TY
JAMA Cardiol; 2016 Oct; 1(7):787-794. PubMed ID: 27541822
[TBL] [Abstract][Full Text] [Related]
8. Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies.
Kesselheim AS; Bykov K; Avorn J; Tong A; Doherty M; Choudhry NK
Ann Intern Med; 2014 Jul; 161(2):96-103. PubMed ID: 25023248
[TBL] [Abstract][Full Text] [Related]
9. Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality.
Mathews R; Wang W; Kaltenbach LA; Thomas L; Shah RU; Ali M; Peterson ED; Wang TY
Circulation; 2018 May; 137(20):2128-2138. PubMed ID: 29386204
[TBL] [Abstract][Full Text] [Related]
10. Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.
Huber CA; Meyer MR; Steffel J; Blozik E; Reich O; Rosemann T
Clin Ther; 2019 Jan; 41(1):107-117. PubMed ID: 30591287
[TBL] [Abstract][Full Text] [Related]
11. Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction.
Faridi KF; Peterson ED; McCoy LA; Thomas L; Enriquez J; Wang TY
JAMA Cardiol; 2016 May; 1(2):147-55. PubMed ID: 27437885
[TBL] [Abstract][Full Text] [Related]
12. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients.
Choudhry NK; Setoguchi S; Levin R; Winkelmayer WC; Shrank WH
Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1189-96. PubMed ID: 18956426
[TBL] [Abstract][Full Text] [Related]
13. The association of pre- and posthospital medication adherence in myocardial infarction patients.
Doll JA; Hellkamp AS; Thomas L; Fonarow GC; Peterson E; Wang TY
Am Heart J; 2019 Feb; 208():74-80. PubMed ID: 30580129
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
[TBL] [Abstract][Full Text] [Related]
15. Retrospective cohort study of medication adherence and risk for 30-day hospital readmission in a Medicare Cost Plan.
Hochhalter AK; Basu R; Prasla K; Jo C
Manag Care; 2014 Jan; 23(1):43-7. PubMed ID: 24765750
[TBL] [Abstract][Full Text] [Related]
16. Full coverage for preventive medications after myocardial infarction.
Choudhry NK; Avorn J; Glynn RJ; Antman EM; Schneeweiss S; Toscano M; Reisman L; Fernandes J; Spettell C; Lee JL; Levin R; Brennan T; Shrank WH;
N Engl J Med; 2011 Dec; 365(22):2088-97. PubMed ID: 22080794
[TBL] [Abstract][Full Text] [Related]
17. [Adherence to medication after myocardial infarction and its impact on outcome: a registry-based analysis from the Hungarian Myocardial Infarction Registry].
Jánosi A; Ofner P; Kiss Z; Kiss L; Kiss RG; Dinnyés J; Járai Z; Nagy G; Veress G; Ferenci T
Orv Hetil; 2017 Jul; 158(27):1051-1057. PubMed ID: 28670984
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective medication adherence in Western Australians in the first year after myocardial infarction: restricted cubic spline analysis of adherence-outcome relationships.
Greenland M; Knuiman MW; Hung J; Nedkoff L; Arnet I; Rankin JM; Kilkenny MF; Sanfilippo FM
Sci Rep; 2020 Mar; 10(1):4315. PubMed ID: 32152400
[TBL] [Abstract][Full Text] [Related]
19. The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction.
Di Martino M; Kirchmayer U; Agabiti N; Bauleo L; Fusco D; Perucci CA; Davoli M
BMJ Open; 2015 Jun; 5(6):e007866. PubMed ID: 26063569
[TBL] [Abstract][Full Text] [Related]
20. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes.
Choudhry NK; Glynn RJ; Avorn J; Lee JL; Brennan TA; Reisman L; Toscano M; Levin R; Matlin OS; Antman EM; Shrank WH
Am Heart J; 2014 Jan; 167(1):51-58.e5. PubMed ID: 24332142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
